ME
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
10.995
Exchange
XNAS - Nasdaq
0.12 B
Last period CFO ,USD
150%
CFO has increased in 5 years
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Medpace
Company Analysis
MEDP valuation, rating, competitors, insights and company profile
Eyestock Rating
MEDP financial analysis by Eyestock methodology
Valuation
MEDP valuation using historical relative method
Statements
MEDP Income Statements, Balance Sheet and Cash Flow Statements
Dividends
MEDP dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
Medpace`s CFO for the period ended 2024-06-30 is 0.12 B USD
